Perfluorocarbon nanomaterials for photodynamic therapy.

Area of Science:

• Biomedical Engineering
• Photochemistry
• Nanotechnology

Background:

• Photodynamic therapy (PDT) is a cancer treatment that utilizes photosensitizers and light to generate cytotoxic reactive oxygen species (ROS).
• Tumor hypoxia is a significant challenge in PDT, as it limits the production of ROS and reduces treatment effectiveness.
• Efficient delivery of both photosensitizers and oxygen to hypoxic tumor microenvironments is crucial for improving PDT outcomes.

Purpose of the Study:

• To review the advantages and disadvantages of using fluorinated nanomaterial architectures for co-delivering oxygen and photosensitizers in PDT.
• To explore how perfluorocarbons can enhance oxygen availability in tumors for improved photodynamic therapy.

Main Methods:

• Review of existing literature on perfluorocarbon-based nanomaterials and their application in photodynamic therapy.
• Analysis of the properties of fluorinated nanomaterials, focusing on their capacity for gas solubility and drug delivery.
• Evaluation of different fluorinated nanomaterial architectures designed for enhanced oxygen and photosensitizer delivery.

Main Results:

• Perfluorocarbons exhibit high gas solubility, making them suitable for co-delivering oxygen to hypoxic tissues.
• Various fluorinated nanomaterial architectures have been developed to facilitate the combined delivery of photosensitizers and oxygen.
• These nanomaterials show potential for overcoming tumor hypoxia and augmenting PDT efficacy.

Conclusions:

• Fluorinated nanomaterials represent a promising strategy for enhancing photodynamic therapy by addressing tumor hypoxia.
• The reviewed architectures offer distinct benefits and limitations that need consideration for clinical translation.
• Further research into optimizing these delivery systems is warranted to maximize their therapeutic potential in cancer treatment.